Prolight Diagnostics
20.85 SEK
+4.77 %
Less than 1K followers
PRLD
Nordic SME
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+4.77 %
+16.48 %
+6.92 %
-5.23 %
-19.19 %
+47.91 %
-11.02 %
-90.53 %
-47.03 %
Prolight Diagnostics develops point-of-care (POC) systems. These are small mobile instruments with disposable test cards that can perform In-Vitro Diagnostic (IVD) tests from a drop of blood. The POC system can contribute to faster and more accurate diagnoses of acute conditions. The company's launch product will be a highly sensitive measurement of troponin to be able to determine and exclude heart attacks.
Read moreMarket cap
251.13M SEK
Turnover
266.04K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26.2
2026
Annual report '25
26.5
2026
Interim report Q1'26
26.5
2026
General meeting '26
All
Press releases
3rd party
ShowingAll content types
BioStock: Prolight Diagnostics reaches high-sensitivity troponin assay design freeze – a key milestone for Psyros
Prolight Diagnostics achieves assay design freeze for Psyros™ point-of-care cartridge – A key milestone toward commercialisation
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools